1998
DOI: 10.1016/s1010-7940(97)00309-6
|View full text |Cite
|
Sign up to set email alerts
|

Tissue engineering: A new approach in cardiovascular surgery; Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh1

Abstract: These results are a first step to demonstrate that seeding of human fibroblasts and endothelial cells on PGA-mesh might be a feasible model to construct human tissues such as vessels or cardiac valves.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
40
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 80 publications
(40 citation statements)
references
References 12 publications
0
40
0
Order By: Relevance
“…PLA is a biocompatible and biodegradable synthetic polymeric material that has attracted great attention as a surgical repair material, e.g., for the development of synthetic vascular grafts (29)(30)(31) and medical sutures (32,33) and as a temporary scaffold for cell growth in tissue-engineering applications (14,15,(17)(18)(19). Generally, scaffolds fabricated from PLA, a hydrophobic polymer, have to be pretreated with ethanol to achieve cell spreading.…”
Section: Resultsmentioning
confidence: 99%
“…PLA is a biocompatible and biodegradable synthetic polymeric material that has attracted great attention as a surgical repair material, e.g., for the development of synthetic vascular grafts (29)(30)(31) and medical sutures (32,33) and as a temporary scaffold for cell growth in tissue-engineering applications (14,15,(17)(18)(19). Generally, scaffolds fabricated from PLA, a hydrophobic polymer, have to be pretreated with ethanol to achieve cell spreading.…”
Section: Resultsmentioning
confidence: 99%
“…Out of these vessels, two cell types can be isolated: Endothelial cells (ECs) with antithrombogenic properties and myofibroblasts capable of ECM development [16][17][18]. After preliminary studies, mainly in sheep [16][17][18][19][20][21], the potential of human vascular-derived cells was evaluated by seeding on biodegradable scaffolds and revealed excellent tissue formation [15,22,23]. A promising alternative cell source for regenerative medicine is bone marrow-derived stem cells (BMSCs) [3,24,25].…”
Section: Strategies In Tissue Engineering: In Vivo or Ex Vivo?mentioning
confidence: 99%
“…Differentiated ECs have been isolated from vascular sources exhibiting promising results in heart valve tissue engineering [16,19,20,22]. Furthermore, endothelial Another interesting cell source is the umbilical cord, containing several cell types that can be used for heart valve tissue engineering: (1) umbilical cord vein-derived and artery-derived cells, (2) Wharton's Jelly-derived MSCs, and (3) umbilical cord blood-derived EPCs.…”
Section: Strategies In Tissue Engineering: In Vivo or Ex Vivo?mentioning
confidence: 99%
See 1 more Smart Citation
“…Seeding cells onto three-dimensional scaffolds is sequential -myofibroblasts are seeded first, followed by endothelial cells [56]. Due to their better self-renewal capacity, broader plasticity, and immunomodullatory properties comparable to adult fibroblasts, tissue-engineered constructs based on perinatal stem cells in general (and particularly WJ-MSCs) could be an attractive alternative to classical cardiovascular substitutes.…”
Section: Application Of Wj-mscs In Cardiovascu-lar Tissue Engineeringmentioning
confidence: 99%